Navigation Links
The ORIGIN-GRACE study
Date:8/27/2012

Munich, Germany A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.

However, while insulin glargine did significantly reduce the secondary outcomes of the study (the annualised rates of change in maximum CIMT for the common carotid artery and for the common carotid plus bifurcation sites), there was no differences in either the primary or secondary outcomes between the omega-3 polyunsaturated fatty acid supplements and placebo groups.

"Our study demonstrates that in high-risk people with established cardiovascular disease or with cardiovascular risk factors plus type 2 diabetes or pre-diabetes, insulin glargine modestly retards the progression of atherosclerosis," said first investigator Professor Eva Lonn, Professor of Medicine and Population Health Research Scientist at McMaster University, Hamilton, Ontario, Canada.

As background to the trial, known as the Glucose Reduction and Atherosclerosis Continuing Evaluation Study (GRACE) study, Professor Lonn explained that the effects of treatment with insulin titrated to normalise fasting plasma glucose levels and with omega-3 polyunsaturated fatty acid supplements (fish oil supplements) on atherosclerosis progression in people with type 2 diabetes or pre-diabetes are unknown.

The GRACE study assessed the effects of insulin glargine and omega-3 fatty acids by performing yearly high-resolution carotid ultrasound examinations for five years and detailed precise measurements of CIMT. Patients were recruited from 32 centers in seven countries. At baseline patients' mean age was
'/>"/>

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. People of normal weight with belly fat at highest death risk, Mayo Clinic study
2. New Blood Thinner Effient No Better Than Plavix at Preventing Heart Trouble: Study
3. Study examines factors associated with improvement in survival from heart attack in France
4. Study: Clot removal devices successful tools for acute ischemic stroke treatment
5. Global study suggests need for strategies to combat unhealthy lifestyles among the poor and the rich
6. Multiple Brain Tumors Even More Malignant: Study
7. Meditation May Help Fight Loneliness, Study Says
8. Spirituality May Boost Mental Health: Study
9. Study identifies human melanoma stem cells
10. Study helps pancreatic cancer patients make hard choices
11. Anorexics Cant Judge Own Body Size: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... FL (PRWEB) February 27, 2015 With cases ... Miami Dade area, concerned parents look to school administrations to ... lice screenings. Though head lice is a common parasite that ... is a nuisance, causing parents and teachers significant distress. ... lice screenings at the school. This would allow parents ...
(Date:2/27/2015)... Durham, NC (PRWEB) February 27, 2015 ... to addressing the unique challenges faced by women ... DiabetesSisters’ Leadership Institute. The Institute, which aims to ... leaders nationwide, is scheduled for the weekend of ... application process, a rigorous selection of participants was ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The ... Commuter Cities in Florida " report today. To ... the 2013 U.S. Census Bureau survey, considering only ... time of the survey. , The report visualizes ... methods of commuting and a breakdown of commute ...
(Date:2/27/2015)... February 27, 2015 Ticket Down announces that ... during the summer months of 2015. Tickets for his ... sell out at a record pace. , Ed ... TX Frank Erwin Center, Wednesday, May 6, 2015 , 5/7/15, ... Prairie, Thursday, May 7, 2015 , 5/9/15, Ed Sheeran Tickets, ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Local lice removal ... rise, particularly in the areas of Pinecrest, Key Biscayne, Coral ... and frustrated as they attempt to isolate and eradicate the ... the common “selfie” photograph may be partly to blame. As ... the kind of head-to-head contact that can allow for the ...
Breaking Medicine News(10 mins):Health News:South Florida Parents Put Pressure on Schools to Perform Lice Screenings to Prevent Spread of Lice According to One Miami Lice Removal Company Called Lice Troopers 2Health News:DiabetesSisters Announces 2015 Leadership Institute for April 24-26, 2015 2Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 3Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 4Health News:Parents frustrated as selfies continue to contribute to the spread of head lice in Miami according to the largest Lice Removal Service in Miami called Lice Troopers 2
... Canadian study finds increase in non-serious side effects , , ... compounds called cannabinoids from the marijuana plant don,t increase ... with an increase in some non-serious side effects, Canadian ... Montreal and the University of British Columbia (UBC) examined ...
... introduces its Contract Research Development as an invaluable resource to medical ... ... 2008 -- Zeus, Inc. introduced its Contract Research Development at the ... the Jacob K. Javits Convention Center in New York. Showcasing ...
... its wholly-owned subsidiary Embryome Sciences, Inc. announced ... International Embryome Initiative, an international collaboration with ... first systematic map of all the cell ... In a paper published today titled “The ...
... /PRNewswire-FirstCall/,-- Schering-Plough Corp. (NYSE: SGP ) and ... the withdrawal of the New Drug Application (NDA) ... terminated the Schering-Plough/Merck Pharmaceuticals,respiratory joint venture, which was ... fixed-combination product that would combine loratadine and,montelukast. This ...
... augment MDS Analytical Technologies, cellular ... ... /PRNewswire-FirstCall/ - MDS Analytical,Technologies, a leader in innovative solutions ... has acquired California-based,Blueshift Biotechnologies (Sunnyvale, CA) for $13 million. ...
... Clinical Development Program Investigating Golimumab in the ... Basis for the Application, HORSHAM, Pa., June ... License Application (BLA) has been submitted to the ... of golimumab,(CNTO 148) as a monthly subcutaneous treatment ...
Cached Medicine News:Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2Health News:Contract Research Development Debuts at MD&M Touting Expertise, Innovation and Collaboration 2Health News: BioTime, Inc. and Embryome Sciences, Inc. Launch Embryome.com and the International Embryome Initiative 2Health News: BioTime, Inc. and Embryome Sciences, Inc. Launch Embryome.com and the International Embryome Initiative 3Health News: BioTime, Inc. and Embryome Sciences, Inc. Launch Embryome.com and the International Embryome Initiative 4Health News:MDS Analytical Technologies Acquires Blueshift Biotechnologies 2Health News:Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2Health News:Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3Health News:Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4Health News:Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5
(Date:2/26/2015)... Calif. , Feb. 26, 2015  BD Life ... Company) (NYSE: BDX ), a leading ... innovative company focused on enabling high-resolution biology, today ... unique solutions for highly multiplexed cell isolation and ... are promoting BD,s powerful BD FACS™ single-cell sorting ...
(Date:2/26/2015)... Feb. 26, 2015  Spring Bank Pharmaceuticals, Inc., ... the treatment of virus infections, today announced that ... appointed Vice President of Finance, a newly created ... and administrative activities, including financial planning and reporting, ... Douglas J. Jensen , President and CEO. ...
(Date:2/26/2015)... , Feb. 26, 2015 Integrity Applications, Inc. ... GlucoTrack ® model DF-F, a noninvasive  device that tracks ... Heinemann , Ph.D., will head its new scientific advisory ... in the field of Diabetes research, monitoring and treatment. ... has been Chief Executive Officer and Head, Business Development ...
Breaking Medicine Technology:BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4
... Reportlinker.com announces that a new market research report ... Hospital Angiography Census http://www.reportlinker.com/p0362433/Hospital-Angiography-Census.html ... European market report on the installed base of ... CT, MRI,) and radiology IT systems (PACS, Teleradiology, ...
... someone needs high-quality drugs for less money, they are sure ... the large choice of pharmacies, it may not be easy ... things simpler and safer for anyone looking to buy ... promotion is the responsibility of the renowned search engine ...
Cached Medicine Technology:Reportlinker Adds Hospital Angiography Census 2Reportlinker Adds Hospital Angiography Census 3New Online Pharmacy Rx-webmasters.com Allows Customers to Pay Less for High-Quality Drugs 2
Bivona® stylets are manufactured of malleable stainless steel wire. The length can be adjusted by sliding the attached silicone stopper. The Blue Line® tracheal tube introducer (bougie) is de...
All endotracheal accessories are designed to ensure your technique. The Blue Line® intubation stylets feature a satin-smooth coating and are available in three sizes....
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
... two groups of flexible lighting products. The ... in three different sizes 5", 10", and ... of the light). These lights are for ... needed., ,The second group of flexible ...
Medicine Products: